Toxic shock syndrome differential diagnosis: Difference between revisions

Jump to navigation Jump to search
Line 61: Line 61:
|  
|  
|-  
|-  
|Lymphadenopathy  
|Lymphadenopathy and conjunctvitis
|Not present  
|Not present  
|Present(acute, non-purulent, cervical)  
|Present(acute, non-purulent, cervical)  
|Cervical lymphadenopathy may be present  
|Cervical lymphadenopathy may be present. Scarlet fever appears similar to Kawasaki's disease in some aspects, but lacks the eye signs or the swollen, red fingers and toes
|-  
|-  
|Metabolic and electrolyte imbalances  
|Metabolic and electrolyte imbalances  
|Present (hyponatremia and uremia)  
|Present (hyponatremia and uremia). Hepatic (total bilirubin, serum asparate aminotransferase or serum alanine aminotransferase levels >2 times upper normal limit)  
|Liver function tests may show evidence of hepatic inflammation and low serum albumin levels  
|Liver function tests may show evidence of hepatic inflammation and low serum albumin levels  
|Not present  
|Not present  
|-
|-
|Hematologic and cardiovascular testing
|Hematologic and cardiovascular testing
|
|Leukocytosis with a polymorphonuclear shift to the left. Platelets < 100,000 per mm<sup>3</sup>
|Low hemoglobulin and age-adjusted hemoglobulin concentrations, thrombocytosis, anemia.  Echocardiographic abnormalities, such as valvulitis (mitral or tricuspid regurgitation) and coronary artery lesions, are significantly more common in the Kawasaki disease. <ref name="pmid26222065">{{cite journal |vauthors=Lin YJ, Cheng MC, Lo MH, Chien SJ |title=Early Differentiation of Kawasaki Disease Shock Syndrome and Toxic Shock Syndrome in a Pediatric Intensive Care Unit |journal=Pediatr. Infect. Dis. J. |volume=34 |issue=11 |pages=1163–7 |year=2015 |pmid=26222065 |doi=10.1097/INF.0000000000000852 |url=}}</ref>
|Low hemoglobulin and age-adjusted hemoglobulin concentrations, '''thrombocytosis''', anemia.  Echocardiographic abnormalities, such as valvulitis (mitral or tricuspid regurgitation) and coronary artery lesions, are significantly more common in the Kawasaki disease. <ref name="pmid26222065">{{cite journal |vauthors=Lin YJ, Cheng MC, Lo MH, Chien SJ |title=Early Differentiation of Kawasaki Disease Shock Syndrome and Toxic Shock Syndrome in a Pediatric Intensive Care Unit |journal=Pediatr. Infect. Dis. J. |volume=34 |issue=11 |pages=1163–7 |year=2015 |pmid=26222065 |doi=10.1097/INF.0000000000000852 |url=}}</ref>
|Leukocytosis with left shift and possibly eosinophilia a few weeks after convalescence. Anti-deoxyribonuclease B, antistreptolysin-O titers (antibodies to streptococcal extracellular products), antihyaluronidase, and antifibrinolysin may be positive.
|}  
|}  
{|
{|

Revision as of 19:21, 9 May 2017

Toxic shock syndrome Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Toxic Shock Syndrome from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Criteria

History and Symptoms

Physical Examination

Laboratory Findings

X Ray

CT

MRI

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Toxic shock syndrome differential diagnosis On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Toxic shock syndrome differential diagnosis

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Toxic shock syndrome differential diagnosis

CDC on Toxic shock syndrome differential diagnosis

Toxic shock syndrome differential diagnosis in the news

Blogs on Toxic shock syndrome differential diagnosis

Directions to Hospitals Treating Toxic shock syndrome

Risk calculators and risk factors for Toxic shock syndrome differential diagnosis

Please help WikiDoc by adding more content here. It's easy! Click here to learn about editing.

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Differentiating Toxic Shock Syndrome from other Diseases

Toxic shock syndrome requires all 3 manifestations of fever, hypotension and diffuse scarlatiniform rash (innumerable small red papules that are diffusely distributed plus erythema, which blanches and desquamates one or two weeks after onset of illness). It presents with various signs of infection, hemodynamic dysfunction and organ failure.

Clinical presentation of sepsis and rash needs to be differentiated from other diseases like:

Features Toxic shock syndrome Kawasaki disease Scarlet fever
Epidemiology Occurs in both adults and children (9:1 female predominance) Occurs in children, usually age 1-4 years Distributed equally among both genders. Most commonly affects children between five and fifteen years of age.
Predisposing factors Occurs in association with vaginitis during menstruation following tampon use (S. aureus); as a complication of soft tissue infections (S. pyogenes or GAS) or in females undergoing medical abortion (C. sordelii). Interaction of genetic and environmental factors, possibly including an infection in combination with genetic predisposition to an autoimmune mechanism (autoimmune vasculitis) Occurs after streptococcal pharyngitis/tonsillitis
Hypotension Commonly present Not present Uncommon
Diarrhea Present May be present Not present
Pastia's sign (puncta and skin crease accentuation of the erythema) Not present Not present Present
Renal faliure Present Not present Uncommon
Pyuria Renal origin Uretheral origin
Lymphadenopathy and conjunctvitis Not present Present(acute, non-purulent, cervical) Cervical lymphadenopathy may be present. Scarlet fever appears similar to Kawasaki's disease in some aspects, but lacks the eye signs or the swollen, red fingers and toes
Metabolic and electrolyte imbalances Present (hyponatremia and uremia). Hepatic (total bilirubin, serum asparate aminotransferase or serum alanine aminotransferase levels >2 times upper normal limit) Liver function tests may show evidence of hepatic inflammation and low serum albumin levels Not present
Hematologic and cardiovascular testing Leukocytosis with a polymorphonuclear shift to the left. Platelets < 100,000 per mm3 Low hemoglobulin and age-adjusted hemoglobulin concentrations, thrombocytosis, anemia. Echocardiographic abnormalities, such as valvulitis (mitral or tricuspid regurgitation) and coronary artery lesions, are significantly more common in the Kawasaki disease. [1] Leukocytosis with left shift and possibly eosinophilia a few weeks after convalescence. Anti-deoxyribonuclease B, antistreptolysin-O titers (antibodies to streptococcal extracellular products), antihyaluronidase, and antifibrinolysin may be positive.

References

  1. Lin YJ, Cheng MC, Lo MH, Chien SJ (2015). "Early Differentiation of Kawasaki Disease Shock Syndrome and Toxic Shock Syndrome in a Pediatric Intensive Care Unit". Pediatr. Infect. Dis. J. 34 (11): 1163–7. doi:10.1097/INF.0000000000000852. PMID 26222065.


Template:WikiDoc Sources